Form 4 for MRNA Moderna
Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-10 · accession 0001127602-22-014263 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-12 | 2022-05-10 | MRNA | Nader Francois | Dir | M - OptEx | $18.87 | +23.1K | 23.8K | +3,286% | +$435.9K |
| D | 2022-05-12 | 2022-05-10 | MRNA | Nader Francois | Dir | S - Sale+OE | $136.10 | -3,196 | 20.6K | -13% | -$435.0K |
| D | 2022-05-12 | 2022-05-10 | MRNA | Nader Francois | Dir | M - OptEx | $0.00 | -23.1K | 16.6K | -58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-10 | M | A | 23,100 | $18.87 | 23,803 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-10 | S | D | 3,196 | $136.10 | 20,607 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.10 to $136.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-05-10 | M | D | 23,100 | $0.00 | 16,620 | D | $18.87 · — to 2029-12-10 | 23,100 Common Stock | (F4) This option is fully vested and exercisable. |